Low Dose Melphalan Is a Treatment Option in Elderly Patients With High Risk Myelodysplastic Syndrome or Secondary Acute Myeloblastic Leukaemia

Haematologia
doi 10.1163/156855902320388023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Brill

Related search

A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Elderly Gastric Cancer Patients With Myelodysplastic Syndrome

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2018English

Effective Treatment of Low-Dose Decitabine in Myelodysplastic Syndrome/Myeloproliferative Neoplasms

OncoTargets and Therapy
OncologyPharmacology
2017English

Phase I Trial of SAR103168, a Novel Multi-Kinase Inhibitor, in Patients With Refractory/Relapsed Acute Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

Safety and Efficacy of Azacitidine in the Treatment of Elderly Patients With Myelodysplastic Syndrome

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2012English

Aplastic Anaemia, Acute Myeloblastic Leukaemia, and Oxymetholone

BMJ
1971English

Amiodarone Infusion in the Treatment of Acute Atrial Fibrillation or Flutter: High Versus Low Dose Treatment

Heart
Cardiovascular MedicineCardiology
2005English

8 Treatment of the Elderly Patient With Acute Myeloid Leukaemia

Baillière's Clinical Haematology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy